Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Lysophosphatidic Acid Upregulates Laminin-332 Expression during A431 Cell Colony Dispersal.

Yamashita H, Tripathi M, Jourquin J, Kam Y, Liu S, Weidow B, Quaranta V.

J Oncol. 2010;2010. pii: 107075. doi: 10.1155/2010/107075. Epub 2010 Aug 25.

2.

Development of high-throughput quantitative assays for glucose uptake in cancer cell lines.

Hassanein M, Weidow B, Koehler E, Bakane N, Garbett S, Shyr Y, Quaranta V.

Mol Imaging Biol. 2011 Oct;13(5):840-52. doi: 10.1007/s11307-010-0399-5.

3.

Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells.

Tripathi M, Potdar AA, Yamashita H, Weidow B, Cummings PT, Kirchhofer D, Quaranta V.

Prostate. 2011 Feb 1;71(2):184-96. doi: 10.1002/pros.21233.

4.

The role of a recombinant fragment of laminin-332 in integrin alpha3beta1-dependent cell binding, spreading and migration.

Yamashita H, Tripathi M, Harris MP, Liu S, Weidow B, Zent R, Quaranta V.

Biomaterials. 2010 Jul;31(19):5110-21. doi: 10.1016/j.biomaterials.2010.03.003. Epub 2010 Mar 27.

5.

Epitope mapping of function-blocking monoclonal antibody CM6 suggests a "weak" integrin binding site on the laminin-332 LG2 domain.

Yamashita H, Shang M, Tripathi M, Jourquin J, Georgescu W, Liu S, Weidow B, Quaranta V.

J Cell Physiol. 2010 Jun;223(3):541-8. doi: 10.1002/jcp.22107.

6.

Laminin-332-beta1 integrin interactions negatively regulate invadopodia.

Liu S, Yamashita H, Weidow B, Weaver AM, Quaranta V.

J Cell Physiol. 2010 Apr;223(1):134-42. doi: 10.1002/jcp.22018.

7.

Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model.

Nandana S, Ellwood-Yen K, Sawyers C, Wills M, Weidow B, Case T, Vasioukhin V, Matusik R.

Prostate. 2010 May 1;70(6):591-600. doi: 10.1002/pros.21093.

8.

Trait variability of cancer cells quantified by high-content automated microscopy of single cells.

Quaranta V, Tyson DR, Garbett SP, Weidow B, Harris MP, Georgescu W.

Methods Enzymol. 2009;467:23-57. doi: 10.1016/S0076-6879(09)67002-6.

9.

Microenvironmental independence associated with tumor progression.

Anderson AR, Hassanein M, Branch KM, Lu J, Lobdell NA, Maier J, Basanta D, Weidow B, Narasanna A, Arteaga CL, Reynolds AB, Quaranta V, Estrada L, Weaver AM.

Cancer Res. 2009 Nov 15;69(22):8797-806. doi: 10.1158/0008-5472.CAN-09-0437. Epub 2009 Nov 3.

10.

Nest expansion assay: a cancer systems biology approach to in vitro invasion measurements.

Kam Y, Karperien A, Weidow B, Estrada L, Anderson AR, Quaranta V.

BMC Res Notes. 2009 Jul 13;2:130. doi: 10.1186/1756-0500-2-130.

11.

A decreased ratio of laminin-332 beta3 to gamma2 subunit mRNA is associated with poor prognosis in colon cancer.

Guess CM, Lafleur BJ, Weidow BL, Quaranta V.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1584-90. doi: 10.1158/1055-9965.EPI-08-1027. Epub 2009 Apr 21.

12.

Migration of isogenic cell lines quantified by dynamic multivariate analysis of single-cell motility.

Harris MP, Kim E, Weidow B, Wikswo JP, Quaranta V.

Cell Adh Migr. 2008 Apr-May;2(2):127-36.

13.

A novel circular invasion assay mimics in vivo invasive behavior of cancer cell lines and distinguishes single-cell motility in vitro.

Kam Y, Guess C, Estrada L, Weidow B, Quaranta V.

BMC Cancer. 2008 Jul 14;8:198. doi: 10.1186/1471-2407-8-198.

14.

Soluble fibrin inhibits lymphocyte adherence and cytotoxicity against tumor cells: implications for cancer metastasis and immunotherapy.

Biggerstaff JP, Weidow B, Dexheimer J, Warnes G, Vidosh J, Patel S, Newman M, Patel P.

Clin Appl Thromb Hemost. 2008 Apr;14(2):193-202. Epub 2007 Dec 26.

PMID:
18160582
15.

A novel and in situ technique for the quantitative detection of MTBE and benzene degrading bacteria in contaminated matrices.

Biggerstaff JP, Le Puil M, Weidow BL, Leblanc-Gridley J, Jennings E, Busch-Harris J, Sublette KL, White DC, Alberte RS.

J Microbiol Methods. 2007 Feb;68(2):437-41. Epub 2006 Nov 3.

PMID:
17084473
16.

Soluble fibrin inhibits monocyte adherence and cytotoxicity against tumor cells: implications for cancer metastasis.

Biggerstaff JP, Weidow B, Vidosh J, Dexheimer J, Patel S, Patel P.

Thromb J. 2006 Aug 22;4:12.

17.

A novel fluorescence imaging technique combining deconvolution microscopy and spectral analysis for quantitative detection of opportunistic pathogens.

Le Puil M, Biggerstaff JP, Weidow BL, Price JR, Naser SA, White DC, Alberte RS.

J Microbiol Methods. 2006 Dec;67(3):597-602. Epub 2006 Aug 2.

PMID:
16887225
18.

Enumeration of leukocyte infiltration in solid tumors by confocal laser scanning microscopy.

Biggerstaff J, Weidow B, Amirkhosravi A, Francis JL.

BMC Immunol. 2006 Jul 21;7:16.

19.

New methodology for viability testing in environmental samples.

Biggerstaff JP, Le Puil M, Weidow BL, Prater J, Glass K, Radosevich M, White DC.

Mol Cell Probes. 2006 Apr;20(2):141-6. Epub 2006 Feb 14.

PMID:
16481147

Supplemental Content

Loading ...
Support Center